Back to Search Start Over

Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years.

Authors :
Piero L Olliaro
Annette C Kuesel
Christine M Halleux
Mark Sullivan
John C Reeder
Source :
PLoS Neglected Tropical Diseases, Vol 12, Iss 11, p e0006837 (2018)
Publication Year :
2018
Publisher :
Public Library of Science (PLoS), 2018.

Details

Language :
English
ISSN :
19352727 and 19352735
Volume :
12
Issue :
11
Database :
Directory of Open Access Journals
Journal :
PLoS Neglected Tropical Diseases
Publication Type :
Academic Journal
Accession number :
edsdoj.2bcdca835654a6a84ce56956c5cf6ea
Document Type :
article
Full Text :
https://doi.org/10.1371/journal.pntd.0006837